BA
The Boeing Company
BA offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
VRSK
Verisk Analytics, Inc.
VRSK has the edge over BA overall, supported by stronger valuation and lower modeled downside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
VRSK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Stable |
VRSK's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over VRSK in the historical PE scenario, which offers more potential upside but is not a forecast.
VRSK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $206 | — |
| Cheap | 29x | $191 | -7.4% |
| Current | 31x | $206 | — |
| Fair | 45x | $294 | +42% |
| Expensive | 59x | $386 | +87% |
Historical ranges are pointers, not guarantees.
VRSK's PE is in its cheap range at 31x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
VRSK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for VRSK, with profitability improving.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
VRSK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.42 | +28% |
| Q3 2026 | $6.59 | +0.3% |
| Q2 2026 | $6.50 | 0% |
| Q1 2026 | $6.56 | -4.1% |
| Q4 2025 | $6.48 | -3.4% |
| Q3 2025 | $6.57 | +3.1% |
| Q2 2025 | $6.50 | +6.2% |
| Q1 2025 | $6.84 | +29% |
| Q4 2024 | $6.71 | +61% |
VRSK has the edge over BA on earnings, with more consistent year-over-year improvement.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
VRSK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $809M | +5.3% |
| Q2 2026 | $806.3M | +4.4% |
| Q1 2026 | $782.6M | +3.9% |
| Q4 2025 | $778.8M | +5.9% |
| Q3 2025 | $768.3M | +5.9% |
| Q2 2025 | $772.6M | +7.8% |
| Q1 2025 | $753M | +7% |
| Q4 2024 | $735.6M | +8.6% |
VRSK's revenue has grown year over year for 12 quarters in a row: $809M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 45% | +0.1 points |
| Q2 2026 | 45% | -0.8 points |
| Q1 2026 | 45% | +1.2 points |
| Q4 2025 | 40% | -2.7 points |
| Q3 2025 | 45% | +2.1 points |
| Q2 2025 | 46% | +1.4 points |
| Q1 2025 | 44% | +0.2 points |
| Q4 2024 | 43% | +6 points |
VRSK has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over VRSK on cash flow, with more consistent year-over-year improvement.
VRSK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $200M | -40% |
| Q2 2026 | $297.9M | +58% |
| Q1 2026 | $326.4M | -17% |
| Q4 2025 | $276.1M | +38% |
| Q3 2025 | $336.1M | +40% |
| Q2 2025 | $188.7M | +23% |
| Q1 2025 | $391M | +23% |
| Q4 2024 | $200M | +2% |
VRSK's free cash flow has been positive every quarter for seven years: $1.1B over the past year, down 1.4% from the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
VRSK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -1.6M shares |
| 1 year | -7.7% | -10.7M shares |
| 3 years | -11% | -16.5M shares |
| 5 years | -21% | -33.6M shares |
| Available history | -22% | -37.3M shares |
VRSK has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $100.1M |
| Q2 2026 | $170.1M |
| Q1 2026 | $1.4B |
| Q4 2025 | $223.8M |
| Q3 2025 | $100.1M |
| Q2 2025 | $100M |
| Q1 2025 | $170.1M |
| Q4 2024 | $315M |
VRSK spent $1.9B buying back its own shares over the past year, up 177% from the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
VRSK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.4x | Moderate |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.9x | Healthy |
VRSK has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
VRSK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.8 | Neutral |
| Stochastic | 71.3 | Neutral |
VRSK's weekly RSI is 60 (neutral) and its Stochastic is 71 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over VRSK on valuation relative to its sector.
VRSK PE vs Industrials Sector
| Metric | VRSK | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 24x | 30% above |
| PE % | 23 | 58 | 35 pts below |
VRSK is trading at 31x earnings, a 30% premium to the Industrials sector's median of 24x.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
VRSK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $188.1 | 9.7% above |
| 20 week MA | $188.3 | 9.6% above |
| 50 week MA | $191.7 | 7.6% above |
| 100 week MA | $234.5 | 12% below |
| 200 week MA | $236.2 | 13% below |
VRSK has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
VRSK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.6 | $201.2 | +35% |
| 2021 | $201.2 | $225.5 | +12% |
| 2022 | $225.5 | $175.6 | -22% |
| 2023 | $175.6 | $238.9 | +36% |
| 2024 | $238.9 | $277.3 | +16% |
| 2025 | $277.3 | $220.3 | -21% |
| 2026 YTD | $220.3 | $206.3 | -6.4% |
VRSK has the edge over BA on returns for 2026, with the stronger performance.